Cargando…
Ixabepilone-induced mitochondria and sensory axon loss in breast cancer patients
BACKGROUND: We sought to define the clinical and ultrastructure effects of ixabepilone (Ix), a microtubule-stabilizing chemotherapy agent on cutaneous sensory nerves and to investigate a potential mitochondrial toxicity mechanism. METHODS: Ten breast cancer patients receiving Ix underwent total neur...
Autores principales: | Ebenezer, Gigi J, Carlson, Karen, Donovan, Diana, Cobham, Marta, Chuang, Ellen, Moore, Anne, Cigler, Tessa, Ward, Maureen, Lane, Maureen E, Ramnarain, Anita, Vahdat, Linda T, Polydefkis, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241791/ https://www.ncbi.nlm.nih.gov/pubmed/25493278 http://dx.doi.org/10.1002/acn3.90 |
Ejemplares similares
-
Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity
por: Stanton, Sasha E, et al.
Publicado: (2015) -
Ixabepilone: a new treatment option for the management of taxane-resistant metastatic breast cancer
por: Cobham, Marta Vallee, et al.
Publicado: (2009) -
Profile and potential of ixabepilone in the treatment of pancreatic cancer
por: Smaglo, Brandon G, et al.
Publicado: (2014) -
Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer
por: Liu, Ying L., et al.
Publicado: (2021) -
Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials
por: Vahdat, Linda T., et al.
Publicado: (2012)